Stay updated on Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata update rather than changes to study content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page shows Revision: v3.4.2 replacing Revision: v3.4.1, indicating a minor version update with no visible changes to study details, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to core content or layout in the provided screenshots.SummaryDifference0.0%

- Check52 days agoChange DetectedThe updates are minor UI/metadata changes (show glossary, capitalization tweaks for QC and FEAR Act data) and a revision bump to v3.4.0, with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive study content or workflow changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.